United States Docetaxel Market Report & Forecast 2021-2027

United States Docetaxel Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Docetaxel Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Docetaxel Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Docetaxel Overall Market Size
2.1 United States Docetaxel Market Size: 2021 VS 2027
2.2 United States Docetaxel Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Docetaxel Sales: 2016-2027
3 Company Landscape
3.1 Top Docetaxel Players in United States Market
3.2 Top United States Docetaxel Companies Ranked by Revenue
3.3 United States Docetaxel Revenue by Companies
3.4 United States Docetaxel Sales by Companies
3.5 United States Docetaxel Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Docetaxel Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Docetaxel Product Type
3.8 Tier 1, Tier 2 and Tier 3 Docetaxel Players in United States Market
3.8.1 List of Tier 1 Docetaxel Companies in United States
3.8.2 List of Tier 2 and Tier 3 Docetaxel Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Docetaxel Market Size Markets, 2021 & 2027
4.1.2 20 mg/ml
4.1.3 40 mg/ml
4.1.4 60 mg/ml
4.2 By Type - United States Docetaxel Revenue & Forecasts
4.2.1 By Type - United States Docetaxel Revenue, 2016-2021
4.2.2 By Type - United States Docetaxel Revenue, 2022-2027
4.2.3 By Type - United States Docetaxel Revenue Market Share, 2016-2027
4.3 By Type - United States Docetaxel Sales & Forecasts
4.3.1 By Type - United States Docetaxel Sales, 2016-2021
4.3.2 By Type - United States Docetaxel Sales, 2022-2027
4.3.3 By Type - United States Docetaxel Sales Market Share, 2016-2027
4.4 By Type - United States Docetaxel Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Docetaxel Market Size, 2021 & 2027
5.1.2 Breast Cancer
5.1.3 Prostate Cancer
5.1.4 Non-small Cell Lung Cancer
5.1.5 Others
5.2 By Application - United States Docetaxel Revenue & Forecasts
5.2.1 By Application - United States Docetaxel Revenue, 2016-2021
5.2.2 By Application - United States Docetaxel Revenue, 2022-2027
5.2.3 By Application - United States Docetaxel Revenue Market Share, 2016-2027
5.3 By Application - United States Docetaxel Sales & Forecasts
5.3.1 By Application - United States Docetaxel Sales, 2016-2021
5.3.2 By Application - United States Docetaxel Sales, 2022-2027
5.3.3 By Application - United States Docetaxel Sales Market Share, 2016-2027
5.4 By Application - United States Docetaxel Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Hengrui Medicine
6.1.1 Hengrui Medicine Corporation Information
6.1.2 Hengrui Medicine Overview
6.1.3 Hengrui Medicine Docetaxel Sales and Revenue in United States Market (2016-2021)
6.1.4 Hengrui Medicine Docetaxel Product Description
6.1.5 Hengrui Medicine Recent Developments
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Overview
6.2.3 Sanofi Docetaxel Sales and Revenue in United States Market (2016-2021)
6.2.4 Sanofi Docetaxel Product Description
6.2.5 Sanofi Recent Developments
6.3 Qilu Pharma
6.3.1 Qilu Pharma Corporation Information
6.3.2 Qilu Pharma Overview
6.3.3 Qilu Pharma Docetaxel Sales and Revenue in United States Market (2016-2021)
6.3.4 Qilu Pharma Docetaxel Product Description
6.3.5 Qilu Pharma Recent Developments
6.4 Shenzhen Main Luck Pharma
6.4.1 Shenzhen Main Luck Pharma Corporation Information
6.4.2 Shenzhen Main Luck Pharma Overview
6.4.3 Shenzhen Main Luck Pharma Docetaxel Sales and Revenue in United States Market (2016-2021)
6.4.4 Shenzhen Main Luck Pharma Docetaxel Product Description
6.4.5 Shenzhen Main Luck Pharma Recent Developments
6.5 Jiangsu Aosaikang Pharma
6.5.1 Jiangsu Aosaikang Pharma Corporation Information
6.5.2 Jiangsu Aosaikang Pharma Overview
6.5.3 Jiangsu Aosaikang Pharma Docetaxel Sales and Revenue in United States Market (2016-2021)
6.5.4 Jiangsu Aosaikang Pharma Docetaxel Product Description
6.5.5 Jiangsu Aosaikang Pharma Recent Developments
7 United States Docetaxel Production Capacity, Analysis
7.1 United States Docetaxel Production Capacity, 2016-2027
7.2 Docetaxel Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Docetaxel Supply Chain Analysis
9.1 Docetaxel Industry Value Chain
9.2 Docetaxel Upstream Market
9.3 Docetaxel Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Docetaxel Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Docetaxel in United States Market
Table 2. Top Docetaxel Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Docetaxel Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Docetaxel Revenue Share by Companies, 2016-2021
Table 5. United States Docetaxel Sales by Companies, (K Units), 2016-2021
Table 6. United States Docetaxel Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Docetaxel Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers Docetaxel Product Type
Table 9. List of Tier 1 Docetaxel Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Docetaxel Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of 20 mg/ml
Table 12. Major Manufacturers of 40 mg/ml
Table 13. By Type - United States Docetaxel Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Docetaxel Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Docetaxel Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Docetaxel Sales (K Units), 2016-2021
Table 17. By Type - United States Docetaxel Sales (K Units), 2022-2027
Table 18. By Application - United States Docetaxel Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Docetaxel Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Docetaxel Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Docetaxel Sales (K Units), 2016-2021
Table 22. By Application - United States Docetaxel Sales (K Units), 2022-2027
Table 23. Hengrui Medicine Corporation Information
Table 24. Hengrui Medicine Description and Major Businesses
Table 25. Hengrui Medicine Docetaxel Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. Hengrui Medicine Docetaxel Product
Table 27. Hengrui Medicine Recent Developments
Table 28. Sanofi Corporation Information
Table 29. Sanofi Description and Major Businesses
Table 30. Sanofi Docetaxel Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. Sanofi Docetaxel Product
Table 32. Sanofi Recent Developments
Table 33. Qilu Pharma Corporation Information
Table 34. Qilu Pharma Description and Major Businesses
Table 35. Qilu Pharma Docetaxel Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. Qilu Pharma Docetaxel Product
Table 37. Qilu Pharma Recent Developments
Table 38. Shenzhen Main Luck Pharma Corporation Information
Table 39. Shenzhen Main Luck Pharma Description and Major Businesses
Table 40. Shenzhen Main Luck Pharma Docetaxel Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. Shenzhen Main Luck Pharma Docetaxel Product
Table 42. Shenzhen Main Luck Pharma Recent Developments
Table 43. Jiangsu Aosaikang Pharma Corporation Information
Table 44. Jiangsu Aosaikang Pharma Description and Major Businesses
Table 45. Jiangsu Aosaikang Pharma Docetaxel Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 46. Jiangsu Aosaikang Pharma Docetaxel Product
Table 47. Jiangsu Aosaikang Pharma Recent Developments
Table 48. Docetaxel Production Capacity (K Units) of Key Manufacturers in United States Market, 2019-2021 (K Units)
Table 49. United States Docetaxel Capacity Market Share of Key Manufacturers, 2019-2021
Table 50. Docetaxel Market Opportunities & Trends in United States Market
Table 51. Docetaxel Market Drivers in United States Market
Table 52. Docetaxel Market Restraints in United States Market
Table 53. Docetaxel Raw Materials
Table 54. Docetaxel Raw Materials Suppliers in United States Market
Table 55. Typical Docetaxel Downstream
Table 56. Docetaxel Downstream Clients in United States Market
Table 57. Docetaxel Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Docetaxel Product Picture
Figure 2. Docetaxel Segment by Type
Figure 3. Docetaxel Segment by Application
Figure 4. United States Docetaxel Market Overview: 2020
Figure 5. United States Docetaxel Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Docetaxel Revenue, 2016-2027 (US$, Mn)
Figure 7. Docetaxel Sales in United States Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Docetaxel Revenue in 2020
Figure 9. 20 mg/ml Product Picture
Figure 10. 40 mg/ml Product Picture
Figure 11. 60 mg/ml Product Picture
Figure 12. By Type - United States Docetaxel Sales Market Share, 2016-2027
Figure 13. By Type - United States Docetaxel Revenue Market Share, 2016-2027
Figure 14. By Type - United States Docetaxel Price (USD/Unit), 2016-2027
Figure 15. Breast Cancer
Figure 16. Prostate Cancer
Figure 17. Non-small Cell Lung Cancer
Figure 18. Others
Figure 19. By Application - United States Docetaxel Sales Market Share, 2016-2027
Figure 20. By Application - United States Docetaxel Revenue Market Share, 2016-2027
Figure 21. By Application - United States Docetaxel Price (USD/Unit), 2016-2027
Figure 22. Hengrui Medicine Docetaxel Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Sanofi Docetaxel Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Qilu Pharma Docetaxel Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Shenzhen Main Luck Pharma Docetaxel Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Jiangsu Aosaikang Pharma Docetaxel Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. United States Docetaxel Production Capacity (K Units), 2016-2027
Figure 28. Docetaxel Industry Value Chain
Figure 29. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs